1. Home
  2. BHB vs IRWD Comparison

BHB vs IRWD Comparison

Compare BHB & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$40.61

Market Cap

675.0M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.47

Market Cap

586.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHB
IRWD
Founded
1887
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
586.6M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
BHB
IRWD
Price
$40.61
$3.47
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
★ $41.00
$6.10
AVG Volume (30 Days)
83.4K
★ 1.6M
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 3.45%
N/A
EPS Growth
N/A
★ 1400.00
EPS
★ 1.71
0.55
Revenue
N/A
★ $298,276,000.00
Revenue This Year
$13.09
$59.19
Revenue Next Year
$4.36
$4.80
P/E Ratio
$23.05
★ $6.46
Revenue Growth
N/A
★ 8.88
52 Week Low
$28.50
$1.47
52 Week High
$41.12
$5.78

Technical Indicators

Market Signals
Indicator
BHB
IRWD
Relative Strength Index (RSI) 65.64 37.03
Support Level $38.82 $3.04
Resistance Level $41.07 $3.96
Average True Range (ATR) 0.80 0.18
MACD 0.22 -0.01
Stochastic Oscillator 94.21 11.97

Price Performance

Historical Comparison
BHB
IRWD

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements, and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, fiduciary services, investment planning, education funding, and individual retirement planning.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: